Vimarsana
Biggest News Aggregation in the World

Page 20 - Linical Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Linical Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Linical Studies Today - Breaking & Trending Today

Histologic Activity in IBD Ups Risk of Serious Infections - Vimarsana News

Histologic Activity in IBD Ups Risk of Serious Infections

Histologic inflammation in IBD emerged as an independent risk factor for serious infection in a large Swedish population-based study.

Physical Activity Gains Last When Financial Rewards Fade - Vimarsana News

Physical Activity Gains Last When Financial Rewards Fade

Withdrawing financial incentives for a physical activity program in Canada after a year led to modest but not clinically meaningful declines.

IV Secukinumab Trials Hit Primary Endpoints in PsA, AxSpA - Vimarsana News

IV Secukinumab Trials Hit Primary Endpoints in PsA, AxSpA

Two phase 3 trials of the recently approved IV formulation of secukinumab showed its efficacy vs placebo in treating psoriatic arthritis and axial spondyloarthritis.

New Trials in GI Cancers: Could Your Patient Benefit? - Vimarsana News

New Trials in GI Cancers: Could Your Patient Benefit?

Maybe one of your patients can join a new clinical trial in noncolorectal gastrointestinal cancer?

What's Behind the Scramble for Semaglutide? - Vimarsana News

What's Behind the Scramble for Semaglutide?

Demand for a diabetes medicine called Ozempic is soaring as people take it to shed pounds, leading to shortages in countries including Britain, Germany, Belgium and the United States.